IN SILICO ANALYSIS OF SINGLE NUCLEOTIDE POLYMORPHISMS IN THE HUMAN TMPRSS2 GENE IN THE PATHOGENESIS OF PROSTATE CANCER
Background: Prostate cancer is a major global health problem, and the TMPRSS2 gene is a key player in its development through androgen-regulated gene fusions. The effect of single nucleotide polymorphisms (SNPs) in TMPRSS2 has not been fully characterized. Methods: SNPs of the human TMPRSS2 gene were retrieved and analyzed in silico. Non-synonymous SNPs (nsSNPs) were evaluated with SIFT, PolyPhen-2, SNPs&GO and PHD-SNP; protein stability was assessed with I-Mutant 3.0 and structural effects with Project HOPE. SNPs in the 3′ UTR and 5′ UTR were analyzed with PolymiRTS and SNPinfo (FuncPred), respectively. Results: Of 122 SNPs retrieved, 105 were nsSNPs, of which 10 were predicted deleterious by SIFT and five probably damaging by PolyPhen-2. Only one variant, rs147711290 (L91P), was predicted deleterious, damaging and disease-associated, and it was predicted to decrease protein stability (DDG = −0.11). Fifteen 3′ UTR SNPs were predicted to affect miRNA binding sites, and two 5′ UTR SNPs (rs151189718 and rs151189719) were identified in a transcription factor binding region. Conclusion: rs147711290 (L91P) is a candidate pathogenic variant of TMPRSS2, and several regulatory UTR SNPs may alter gene expression. These computational findings require validation by wet-lab and clinical studies.
Authors
- Mohammed O. Mussa1*, Asia A. Mohammed1, Kamal A. Abdalla2, Salah E. Idriss3, Tarig B. Algak4
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-15
- DOI
- https://doi.org/10.5281/zenodo.24200317
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00